Virtual Medicinal Product (VMP) - Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Papaveretum 15.4mg/1ml / Hyoscine hydrobromide 400micrograms/1ml solution for injection ampoules Start Date 22-03-2005 End Date
Abbreviated Name Abbreviated Name Papaveretum 15.4mg/Hyoscine hydrobrom 400microg/1ml inj amp Start Date 22-03-2005

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
Schedule 2 (CD)
Route
Subcutaneous, Intramuscular
Form
Solution for injection
Ontology Form/Route
solutioninjection.intramuscular, solutioninjection.subcutaneous
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

BNF Start Date End Date
Current BNF 04070200 Start Date 04-04-2022 End Date
Previous BNF 04070200 Start Date 22-03-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36025411000001105 29-10-2018
333955002 22-03-2005 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Hyoscine hydrobromide Based on Ingredient Substance 400 microgram 1 ml
Papaveretum Based on Ingredient Substance 15.4 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
10 ampoule